Nucleocytoplasmic translocation of UBXN2A is required for apoptosis during DNA damage stresses in colon cancer cells

Journal of Cancer

Volumn 6, Issue 11, 2015, Pages 1066-1078

  Abdullah, Ammara ^a   Sane, Sanam ^a   Freeling, Jessica L ^a   Wang, Hongmin ^a   Zhang, Dong ^b   Rezvani, Khosrow ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Colon cancer cells; DNA damage stress; Mortalin 2; P53; UBXN2A

Indexed keywords

ETOPOSIDE; LEPTOMYCIN B; MORTALIN 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; ONCOPROTEIN; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SHORT HAIRPIN RNA; TUMOR SUPPRESSOR PROTEIN; UBXN2A PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL LINE; CELL COMPARTMENTALIZATION; CELL DEATH; CELL FRACTIONATION; CELL LYSATE; CELLULAR DISTRIBUTION; COLON CANCER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DEPLETION; DNA DAMAGE; DNA STRAND BREAKAGE; ENDOPLASMIC RETICULUM; GENE TRANSLOCATION; HCT116 CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; ULTRAVIOLET B RADIATION; UPREGULATION; WESTERN BLOTTING;

EID: 84947730968     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.12134     Document Type: Article

References (60)

1. Appella E, Anderson CW. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem. 2001; 268: 2764-72.
2. Li Q, Feldman RA, Radhakrishnan VM, Carey S, Martinez JD. Hsf1 is required for the nuclear translocation of p53 tumor suppressor. Neoplasia. 2008; 10: 1138-45.
3. Fritsche M, Haessler C, Brandner G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene. 1993; 8: 307-18.
4. Wadhwa R, Takano S, Robert M, Yoshida A, Nomura H, Reddel RR, et al. Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member. J Biol Chem. 1998; 273: 29586-91.
5. Lu WJ, Lee NP, Kaul SC, Lan F, Poon RT, Wadhwa R, et al. Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy. Cell Death Differ. 2011; 6: 1046-56.
6. Yang HY, Wen YY, Chen CH, Lozano G, Lee MH. 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Mol Cell Biol. 2003; 23: 7096-107.
7. Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 1998; 92: 725-34.
8. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science. 2005; 309: 1732-5.
9. Yuan J, Luo K, Zhang L, Cheville JC, Lou Z. USP10 regulates p53 localization and stability by deubiquitinating p53. Cell. 2010; 140: 384-96.
10. Sane S, Abdullah A, Boudreau DA, Autenried RK, Gupta BK, Wang X, et al. Ubiquitin-like (UBX)-domain-containing protein, UBXN2A, promotes cell death by interfering with the p53-Mortalin interactions in colon cancer cells. Cell Death Dis. 2014; 5: e1118.
11. Jauhiainen A, Thomsen C, Strombom L, Grundevik P, Andersson C, Danielsson A, et al. Distinct cytoplasmic and nuclear functions of the stress induced protein DDIT3/CHOP/GADD153. PLoS One. 2012; 7: e33208.
12. Zhang J, Cao M, Dong J, Li C, Xu W, Zhan Y, et al. ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53. Nat Commun. 2014; 5: 5059.
13. Hsu TI, Wang MC, Chen SY, Yeh YM, Su WC, Chang WC, et al. Sp1 expression regulates lung tumor progression. Oncogene. 2012; 31: 3973-88.
14. Huang Q, Raya A, DeJesus P, Chao SH, Quon KC, Caldwell JS, et al. Identification of p53 regulators by genome-wide functional analysis. Proc Natl Acad Sci U S A. 2004; 101: 3456-61.
15. Abdullah A, Sane S, Branick KA, Freeling JL, Wang H, Zhang D, et al. A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2. Oncotarget. 2015.
16. Bhasin M, Raghava GP. ESLpred: SVM-based method for subcellular localization of eukaryotic proteins using dipeptide composition and PSI-BLAST. Nucleic Acids Res. 2004; 32: W414-9.
17. Alexandru G. Exploring the role of p97 and its UBX-domain cofactors through identification of their interacting proteins. Methods Mol Biol. 2012; 832: 305-12.
18. Tanaka T, Okada M, Hozumi Y, Tachibana K, Kitanaka C, Hamamoto Y, et al. Cytoplasmic localization of DGKzeta exerts a protective effect against p53-mediated cytotoxicity. J Cell Sci. 2013; 126: 2785-97.
19. Latonen L, Taya Y, Laiho M. UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts. Oncogene. 2001; 20: 6784-93.
20. Nicholls CD, Shields MA, Lee PW, Robbins SM, Beattie TL. UV-dependent alternative splicing uncouples p53 activity and PIG3 gene function through rapid proteolytic degradation. J Biol Chem. 2004; 279: 24171-8.
21. Wang Y, Rosenstein B, Goldwyn S, Zhang X, Lebwohl M, Wei H. Differential regulation of P53 and Bcl-2 expression by ultraviolet A and B. J Invest Dermatol. 1998; 111: 380-4.
22. Takasawa R, Nakamura H, Mori T, Tanuma S. Differential apoptotic pathways in human keratinocyte HaCaT cells exposed to UVB and UVC. Apoptosis. 2005; 10: 1121-30.
23. Chen X, Chen J, Gan S, Guan H, Zhou Y, Ouyang Q, et al. DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control. BMC Biol. 2013; 11: 73.
24. Inoue T, Wu L, Stuart J, Maki CG. Control of p53 nuclear accumulation in stressed cells. FEBS Lett. 2005; 579: 4978-84.
25. Lai CY, Tsai AC, Chen MC, Chang LH, Sun HL, Chang YL, et al. Aciculatin induces p53-dependent apoptosis via MDM2 depletion in human cancer cells in vitro and in vivo. PLoS One. 2012; 7: e42192.
26. Kim WH, Yeo M, Kim MS, Chun SB, Shin EC, Park JH, et al. Role of caspase-3 in apoptosis of colon cancer cells induced by nonsteroidal anti-inflammatory drugs. Int J Colorectal Dis. 2000; 15: 105-11.
27. Kondo H, Rabouille C, Newman R, Levine TP, Pappin D, Freemont P, et al. p47 is a cofactor for p97-mediated membrane fusion. Nature. 1997; 388: 75-8.
28. Rezvani K, Teng Y, Pan Y, Dani JA, Lindstrom J, Garcia Gras EA, et al. UBXD4, a UBX-containing protein, regulates the cell surface number and stability of alpha3-containing nicotinic acetylcholine receptors. J Neurosci. 2009; 29: 6883-96.
29. Madsen L, Andersen KM, Prag S, Moos T, Semple CA, Seeger M, et al. Ubxd1 is a novel co-factor of the human p97 ATPase. Int J Biochem Cell Biol. 2008; 40: 2927-42.
30. Yi J, Lu G, Li L, Wang X, Cao L, Lin M, et al. DNA damage-induced activation of CUL4B targets HUWE1 for proteasomal degradation. Nucleic Acids Res. 2015; 43: 4579-90.
31. Alexandru G, Graumann J, Smith GT, Kolawa NJ, Fang R, Deshaies RJ. UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. Cell. 2008; 134: 804-16.
32. Meyer H. p97 complexes as signal integration hubs. BMC Biol. 2012; 10: 48.
33. Sen N, Kumari R, Singh MI, Das S. HDAC5, a key component in temporal regulation of p53-mediated transactivation in response to genotoxic stress. Mol Cell. 2013; 52: 406-20.
34. Kurki S, Latonen L, Laiho M. Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization. J Cell Sci. 2003; 116: 3917-25.
35. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol. 2008; 9: 402-12.
36. Amiri F, Zarnani AH, Zand H, Koohdani F, Jeddi-Tehrani M, Vafa M. Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines. Eur J Pharmacol. 2013; 718: 34-40.
37. Soldani C, Bottone MG, Pellicciari C, Scovassi AI. Two-color fluorescence detection of Poly (ADP-Ribose) Polymerase-1 (PARP-1) cleavage and DNA strand breaks in etoposide-induced apoptotic cells. Eur J Histochem. 2001; 45: 389-92.
38. Soldani C, Lazze MC, Bottone MG, Tognon G, Biggiogera M, Pellicciari CE, et al. Poly(ADP-ribose) polymerase cleavage during apoptosis: when and where? Exp Cell Res. 2001; 269: 193-201.
39. Enns L, Bogen KT, Wizniak J, Murtha AD, Weinfeld M. Low-dose radiation hypersensitivity is associated with p53-dependent apoptosis. Mol Cancer Res. 2004; 2: 557-66.
40. Long BH, Musial ST, Brattain MG. Single-and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide. Cancer Res. 1985; 45: 3106-12.
41. Baumstark-Khan C, Hentschel U, Nikandrova Y, Krug J, Horneck G. Fluorometric analysis of DNA unwinding (FADU) as a method for detecting repair-induced DNA strand breaks in UV-irradiated mammalian cells. Photochem Photobiol. 2000; 72: 477-84.
42. Rastogi RP, Singh SP, Hader DP, Sinha RP. Detection of reactive oxygen species (ROS) by the oxidant-sensing probe 2',7'-dichlorodihydrofluorescein diacetate in the cyanobacterium Anabaena variabilis PCC 7937. Biochem Biophys Res Commun. 2010; 397: 603-7.
43. Ioannou D, Kandukuri L, Quadri A, Becerra V, Simpson JL, Tempest HG. Spatial positioning of all 24 chromosomes in the lymphocytes of six subjects: evidence of reproducible positioning and spatial repositioning following DNA damage with hydrogen peroxide and ultraviolet B. PLoS One. 2015; 10: e0118886.
44. Wilson AJ, Arango D, Mariadason JM, Heerdt BG, Augenlicht LH. TR3/Nur77 in colon cancer cell apoptosis. Cancer Res. 2003; 63: 5401-7.
45. Marchenko ND, Hanel W, Li D, Becker K, Reich N, Moll UM. Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-alpha3 binding. Cell Death Differ. 2010; 17: 255-67.
46. Kaul SC, Aida S, Yaguchi T, Kaur K, Wadhwa R. Activation of wild type p53 function by its mortalin-binding, cytoplasmically localizing carboxyl terminus peptides. J Biol Chem. 2005; 280: 39373-9.
47. Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 1998; 12: 2973-83.
48. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 2004; 303: 1010-4.
49. Wu PK, Hong SK, Veeranki S, Karkhanis M, Starenki D, Plaza JA, et al. A mortalin/HSPA9-mediated switch in tumor-suppressive signaling of Raf/MEK/extracellular signal-regulated kinase. Mol Cell Biol. 2013; 33: 4051-67.
50. Yang L, Guo W, Zhang Q, Li H, Liu X, Yang Y, et al. Crosstalk between Raf/MEK/ERK and PI3K/AKT in suppression of Bax conformational change by Grp75 under glucose deprivation conditions. J Mol Biol. 2011; 414: 654-66.
51. Saar Ray M, Moskovich O, Iosefson O, Fishelson Z. Mortalin/Grp75 Binds to Complement C9 and Plays a Role in Resistance to Complement-Dependent Cytotoxicity. J Biol Chem. 2014.
52. Ryu J, Kaul Z, Yoon AR, Liu Y, Yaguchi T, Na Y, et al. Identification and functional characterization of nuclear mortalin in human carcinogenesis. J Biol Chem. 2014; 289: 24832-44.
53. E. Oki, H. Saeki, T. Ohga, Y. Kakeji, S. Tsujitani, T. Kusumoto, Y. Maehara. Prognostic significance of mortalin expresion in gastric adenocarcinoma with wild-type p53. J Clin Oncol 2011; 29: abstr_e14662.
54. Noble P, Vyas M, Al-Attar A, Durrant S, Scholefield J, Durrant L. High levels of cleaved caspase-3 in colorectal tumour stroma predict good survival. Br J Cancer. 2013; 108: 2097-105.
55. Ishida N, Hara T, Kamura T, Yoshida M, Nakayama K, Nakayama KI. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J Biol Chem. 2002; 277: 14355-8.
56. Carter S, Bischof O, Dejean A, Vousden KH. C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat Cell Biol. 2007; 9: 428-35.
57. Feng Z, Kachnic L, Zhang J, Powell SN, Xia F. DNA damage induces p53-dependent BRCA1 nuclear export. J Biol Chem. 2004; 279: 28574-84.
58. Su Y, Fu C, Ishikawa S, Stella A, Kojima M, Shitoh K, et al. APC is essential for targeting phosphorylated beta-catenin to the SCFbeta-TrCP ubiquitin ligase. Mol Cell. 2008; 32: 652-61.
59. Henderson BR. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat Cell Biol. 2000; 2: 653-60.
60. Li J, Tan J, Zhuang L, Banerjee B, Yang X, Chau JF, et al. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress. Cancer Res. 2007; 67: 11317-26.